Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396196 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RAD54 Homolog B (S. Cerevisiae) (RAD54B) (AA 801-910) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 801-910
- Isotype
- IgG
- Antibody clone number
- 4A7
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.
Variation within DNA repair pathway genes and risk of multiple sclerosis.
Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML
Carcinogenesis 2010 Oct;31(10):1762-9
Carcinogenesis 2010 Oct;31(10):1762-9
Variation within DNA repair pathway genes and risk of multiple sclerosis.
Briggs FB, Goldstein BA, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, Haines JL, Barcellos LF, International Multiple Sclerosis Genetics Consortium.
American journal of epidemiology 2010 Jul 15;172(2):217-24
American journal of epidemiology 2010 Jul 15;172(2):217-24
Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.
McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Couch FJ, Cunningham JM, Matsumoto ME, Rabe KG, Hammer TJ, Petersen GM
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Sep;18(9):2549-52
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Sep;18(9):2549-52
Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.
McManus KJ, Barrett IJ, Nouhi Y, Hieter P
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 3;106(9):3276-81
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 3;106(9):3276-81
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
Kweekel DM, Antonini NF, Nortier JW, Punt CJ, Gelderblom H, Guchelaar HJ
British journal of cancer 2009 Jul 21;101(2):357-62
British journal of cancer 2009 Jul 21;101(2):357-62
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA